September 25, 2017 / 12:15 PM / 3 months ago

BRIEF-Novan conducts guidance meeting with FDA on SB204 development program

Sept 25 (Reuters) - Novan Inc

* Novan conducts guidance meeting with FDA on SB204 development program

* Novan Inc - ‍concluded a guidance meeting with U.S FDA regarding SB204 for treatment of acne vulgaris​

* Novan Inc - ‍FDA advised that an additional pivotal trial should be conducted​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below